Professional Documents
Culture Documents
pharmaceutics
- The study how various dosage forms influence the way which ‣ Parenteral medication has higher
drug affects the body. concentration that oral
- Formulation of drugs to their delivery & disposition in the body medications.
to help them achieve therapeutic effects at their sites of
action. ‣ Parenteral is faster than oral
‣ Enteral & Parenteral Drugs
➡ 80% of drugs are taken orally (enteral)
➡ Oral meds must be disintegrated & combined with a
solution to be absorbed by the GI tract & into the ➡ Factors affecting Bioavailability:
bloodstream 1. Drug Form: tablets, capsule, liquid,
➡ Parenteral drugs do not pass the GI tract.
transdermal patch, suppository, inhalation
‣ Disintegration VS. Dissolution
2. Route of Administration: enteral, topical,
➡ Disintegration: Breakdown of tablet into smaller or parenteral
particles. ‣ First-Pass Metabolism: A fraction of
➡ Dissolution: Dissolving of smaller particles in the GI the drug can be metabolized in the liver
tract. before it even reaches the systemic
circulation. Makes the bioavailability of
the drug reduced. Oral & Rectal route.
✓ Oral drugs have lower plasma
concentration; Rectal drugs are
suppository.
‣ Enteric-coated drugs
➡ Polymer barrier applied on oral medication that ✓ Sublingual & Buccal route won’t
prevents its dissolution or disintegration in the gastric Hepatic First-Pass Metabolism
environment, causing delayed onset/sustained release. (HFPM); not all drugs can be
➡ Don’t crush; designed not to be dissolved immediately sublingual.
3. GI Mucosal Integrity & Motility
4. Administration With Food or Other
Drugs
2 of 5 2 n u 0 8 : D o m i n i qu e U y
5. Disease: Change in liver metabolism due to • Drugs that dissolve in fat
liver dysfunction or decrease in hepatic blood • EX: Anti-anxiety drug, Clorazepate, tends to
flow concentrate in fatty tissues.
‣ Protein Binding
- Drug Absorption Through GI Membrane:
➡ Degree to which medications attach to proteins
within the blood.
➡ Common Blood Proteins that Drug Bind:
• Albumin
‣ Abundant protein in the body
‣ Mainly synthesized in the liver
‣ Responsible for the oncotic (“pulls water”)
pressure inside the cell.
• Lipoprotein
• Glycoprotein
• α, β‚ & γ Globulins
➡ Free drugs
• AKA Unbound drug
• An active drug or other compound that is not
bound to a carrier protein.
‣ Active Absorption: energy department (ATP)
➡ Requires an enzyme or protein - may be from
low to high concentration ‼ Remember:
‣ Passive Absorption: no energy • The less bound a drug is, the more efficiently it can traverse cell
➡ Diffusion - high to low concentration membranes or diffuse.
➡ Facilitated Diffusion - rely on carrier protein
from high to low concentration - Volume of Drug Distribution (Vd)
‣ Pinocytosis: ‣ Volume at which drug would need to be uniformly
➡ Cells carry drug across membrane by distributed to produce an observed blood
engulfing drug particles concentration
- Factors Affecting Drug Absorption: ‣ Calculated as the ration of the dose present in the
> Blood flow > Fasting body & its plasma concentration.
‼ Remember:
• Certain drugs need acid for better absorption (thus taken ‣ Interstitial Fluid can be
after meals) penetrated by water-soluble
& low molecular weight
3. Distribution
drugs
3 of 5 2 n u 0 8 : D o m i n i qu e U y
- Half-life (t1⁄2) ‣ Antagonists: Prevent receptor activation; drugs that
‣ Time it takes for one-half of the drug concentration “block” a response.
to be eliminated.
‣ Takes approximately six half-lives for a drug to be
eliminated around 98%
‣ Almost all drugs, not all drugs are applicable to
half-life
‣ EX: 12pm 100mg (every 4 hours)
4pm 50mg
8pm 25mg
12am 12.5mg
- Loading Dose: Initial higher dose of a drug that may
be given at the beginning of a course of treatment
before dropping down lower maintenance dose.
- Enzyme Inducers VS. Enzyme Inhibitors
‣ Inducer = increases metabolism -> increase ‼ Remember:
elimination -> decrease drug concentration
• The drug agonist that has an exact fit with a receptor
‣ Inhibitor = decreases metabolism -> decrease is a strong agonist & is more biologically active.
elimination -> increase drug concentration
➡ Ex: Drug A = Warfarin (Blood Thinner)
Drug Response
Drug B = Enzyme Inhibitor (Inducer)
————————————————————————————————- 1. Tachyphylaxis
Bleeding (Clotting) ‣ Rapidly diminishing response to successive dosage of a
drug, rendering it less effective.
5. Excretion
- Most drugs, particularly water-soluble drugs & their 2. Placebo Effect
‼ Remember:
• Drugs should be metabolized to water-soluble
for it to be excreted.
4 of 5 2 n u 0 8 : D o m i n i qu e U y
onset, peak, & duration of action Therapeutic Window
- Onset: Time it takes to reach the minimum effective - Range of doses that produces therapeutic response without
concentration (MEC) after a drug is administered. causing any significant adverse effect in patients.
- Between the minimum effective concentration (MEC) & the
- Peak Action: Occurs when the drug reaches its highest blood
minimum toxic concentration (MTC) non-specific drug effect
or plasma concentration. - Safe range for drug dosage
- Duration of Action: Length of time the drug has a
pharmacological effect.
Therapeutic failure
- Failure to achieve or maintain desired therapeutic effect of a
drug.
non-specific drug effect - Causes of Therapeutic Failure:
> Poor Compliance > Quality of Drugs
> Factors affecting Biotransformation > Drug Tolerance
> Factors affecting Bioavailability > Inappropriate
Indication
> Drug Interactions > Untoward effects
5 of 5 2 n u 0 8 : D o m i n i qu e U y